NNKTT120, an Anti-iNKT Cell Monoclonal Antibody, Produces Rapid and Sustained INKT Cell Depletion in Adults with Sickle Cell Disease

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Feb 3

PMID 28152086

Citations 21

Authors

Joshua J Field

Elaine Majerus

Kenneth I Ataga

Elliot P Vichinsky

Robert Schaub

Robert Mashal

David G Nathan

Affiliations

Soon will be listed here.

Abstract

Trial Registration: clinicaltrials.gov NCT01783691.

Citing Articles

T Cell Receptor-Engaging Monoclonal Antibodies Mobilize the Anti-Tumor Functions of Invariant Natural Killer T Cells.

Das R Crit Rev Oncog. 2024; 29(1):69-81.

PMID: 38421715 PMC: 11062185. DOI: 10.1615/CritRevOncog.2023049947.

Real-time prediction of bladder urine leakage using fuzzy inference system and dual Kalman filtering in cats.

Qasemi A, Aminian A, Erfanian A Sci Rep. 2024; 14(1):3879.

PMID: 38365925 PMC: 10873426. DOI: 10.1038/s41598-024-53629-5.

Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies.

Rabin J, Zhao Y, Mostafa E, Al-Suqi M, Fleischmann E, Conaway M PLoS One. 2023; 18(8):e0288920.

PMID: 37566593 PMC: 10420352. DOI: 10.1371/journal.pone.0288920.

Acute chest syndrome, airway inflammation and lung function in sickle cell disease.

De A, Williams S, Yao Y, Jin Z, Brittenham G, Kattan M PLoS One. 2023; 18(3):e0283349.

PMID: 36996064 PMC: 10062579. DOI: 10.1371/journal.pone.0283349.

Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative.

Treadwell M, Du L, Bhasin N, Marsh A, Wun T, Bender M Front Genet. 2022; 13:921432.

PMID: 36092883 PMC: 9461276. DOI: 10.3389/fgene.2022.921432.

References

Field J, Lin G, Okam M, Majerus E, Keefer J, Onyekwere O . Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood. 2013; 121(17):3329-34. PMC: 3637009. DOI: 10.1182/blood-2012-11-465963. View

Cox D, Fox L, Tian R, Bardet W, Skaley M, Mojsilovic D . Determination of cellular lipids bound to human CD1d molecules. PLoS One. 2009; 4(5):e5325. PMC: 2673035. DOI: 10.1371/journal.pone.0005325. View

Scheuplein F, Lamont D, Poynter M, Boyson J, Serreze D, Lundblad L . Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo. PLoS One. 2015; 10(10):e0140729. PMC: 4608835. DOI: 10.1371/journal.pone.0140729. View

De Santo C, Salio M, Masri S, Lee L, Dong T, Speak A . Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest. 2008; 118(12):4036-48. PMC: 2582442. DOI: 10.1172/JCI36264. View

Gapin L, Matsuda J, Surh C, Kronenberg M . NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol. 2001; 2(10):971-8. DOI: 10.1038/ni710. View

Wallace K, Marshall M, Ramos S, Lannigan J, Field J, Strieter R . NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood. 2009; 114(3):667-76. PMC: 2713467. DOI: 10.1182/blood-2009-02-205492. View

Fox L, Cox D, Lockridge J, Wang X, Chen X, Scharf L . Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol. 2009; 7(10):e1000228. PMC: 2760207. DOI: 10.1371/journal.pbio.1000228. View

Steinberg M, Mccarthy W, Castro O, Ballas S, Armstrong F, Smith W . The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. Am J Hematol. 2010; 85(6):403-8. PMC: 2879711. DOI: 10.1002/ajh.21699. View

Thomas S, Scanlon S, Griewank K, Constantinides M, Savage A, Barr K . PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med. 2011; 208(6):1179-88. PMC: 3173247. DOI: 10.1084/jem.20102630. View

10.

Styles L, Schalkwijk C, Aarsman A, Vichinsky E, Lubin B, Kuypers F . Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood. 1996; 87(6):2573-8. View

11.

Starr T, Jameson S, Hogquist K . Positive and negative selection of T cells. Annu Rev Immunol. 2002; 21:139-76. DOI: 10.1146/annurev.immunol.21.120601.141107. View

12.

Balato A, Unutmaz D, Gaspari A . Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Invest Dermatol. 2009; 129(7):1628-42. DOI: 10.1038/jid.2009.30. View

13.

Tupin E, Kinjo Y, Kronenberg M . The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol. 2007; 5(6):405-17. DOI: 10.1038/nrmicro1657. View

14.

Dhodapkar M, Geller M, Chang D, Shimizu K, Fujii S, Dhodapkar K . A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J Exp Med. 2003; 197(12):1667-76. PMC: 2193955. DOI: 10.1084/jem.20021650. View

15.

Dial E, Tran D, Romero J, Zayat M, Lichtenberger L . A direct role for secretory phospholipase A2 and lysophosphatidylcholine in the mediation of LPS-induced gastric injury. Shock. 2009; 33(6):634-8. PMC: 2875268. DOI: 10.1097/SHK.0b013e3181cb9266. View

16.

Lappas C, Day Y, Marshall M, Engelhard V, Linden J . Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med. 2006; 203(12):2639-48. PMC: 2118143. DOI: 10.1084/jem.20061097. View

17.

Wallace K, Linden J . Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood. 2010; 116(23):5010-20. PMC: 3012594. DOI: 10.1182/blood-2010-06-290643. View

18.

Shen L, Zhang H, Caimol M, Benike C, Chakravarty E, Strober S . Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production. Eur J Immunol. 2014; 45(2):612-23. PMC: 4324163. DOI: 10.1002/eji.201444760. View

19.

Vincent M, Gumperz J, Brenner M . Understanding the function of CD1-restricted T cells. Nat Immunol. 2003; 4(6):517-23. DOI: 10.1038/ni0603-517. View

20.

Zhang D, Xu C, Manwani D, Frenette P . Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood. 2016; 127(7):801-9. PMC: 4760086. DOI: 10.1182/blood-2015-09-618538. View